Year archive

Leadway Technology Investment Group Limited — 2025 filings

All 83 regulatory filings released by Leadway Technology Investment Group Limited (2086) in 2025, sourced directly from the official regulator.

83 Filings

2025 Period

2025 filings (83)

Filing	Released	Lang
Discloseable Transaction - Subscription of Wealth Management Product with Industrial Bank Capital/Financing Update	2025-12-24	English
Renewal of Existing Continuing Connected Transactions with Tianjin Pharmaceutical Group Co., Ltd. Regulatory Filings	2025-12-22	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2025 Share Issue/Capital Change	2025-12-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-01	English
Discloseable Transaction - Subscription of Wealth Management Product with Industrial Bank Regulatory Filings	2025-11-19	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Governance Information	2025-11-19	English
RESIGNATION OF NON-EXECUTIVE DIRECTOR Board/Management Information	2025-11-18	English
Poll Results of the Extraordinary General Meeting held on 13 November 2025 Declaration of Voting Results & Voting Rights Announcements	2025-11-13	English
Discloseable Transaction - Subscription of Wealth Management Product Regulatory Filings	2025-11-11	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2025 Regulatory Filings	2025-11-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-03	English
Unaudited Financial Results for the nine months ended 30 September 2025 of Tianjin Lisheng Pharmaceutical Co., Ltd. Interim / Quarterly Report 9M 2025	2025-10-24	English
Notification Letter to Non-registered Shareholders and Request Form Report Publication Announcement	2025-10-17	English
Notification Letter to Existing Shareholders and Request Form Report Publication Announcement	2025-10-17	English
Notice of Extraordinary General Meeting Proxy Solicitation & Information Statement	2025-10-17	English
Form of Proxy for Extraordinary General Meeting to be held on 13 November 2025 Proxy Solicitation & Information Statement	2025-10-17	English
Discloseable and Connected Transaction - Formation of Fund and Notice of Extraordinary General Meeting Regulatory Filings	2025-10-17	English
Discloseable and Connected Transaction - Formation of Fund and Notice of Extraordinary General Meeting Proxy Solicitation & Information Statement	2025-10-17	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2025 Regulatory Filings	2025-10-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-02	English
Interim Report 2025 Interim / Quarterly Report H1 2025	2025-09-23	English
Notification Letter to Non-registered Shareholders and Request Form Report Publication Announcement	2025-09-19	English
Notification Letter to Existing Shareholders and Request Form Report Publication Announcement	2025-09-19	English
2025 Interim Report Interim / Quarterly Report H1 2025	2025-09-19	English
Announcement Pursuant to Rule 13.18 of the Listing Rules Capital/Financing Update	2025-09-17	English
Discloseable and Connected Transaction - Formation of Fund Regulatory Filings	2025-09-10	English
Discloseable Transaction - Subscription of Wealth Management Product with Industrial Bank Regulatory Filings	2025-09-10	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2025 Regulatory Filings	2025-09-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-01	English
Interim Dividend for the six months ended 30 June 2025 Notice of Dividend Amount	2025-08-28	English
Announcement of Interim Results for the six months ended 30 June 2025 Interim / Quarterly Report H2 2025	2025-08-28	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 Interim / Quarterly Report H2 2025	2025-08-26	English
Unaudited Financial Results for the six months ended 30 June 2025 of Tianjin Lisheng Pharmaceutical Co., Ltd. Interim / Quarterly Report H2 2025	2025-08-22	English
Potential Discloseable and Connected Transaction - Formation of Fund Capital/Financing Update	2025-08-22	English
Date of Board Meeting Regulatory Filings	2025-08-18	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-08-14	English
PROFIT WARNING Regulatory Filings	2025-08-08	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2025 Regulatory Filings	2025-08-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Regulatory Filings	2025-08-01	English
Overseas Regulatory Announcement Earnings Release H1 2025	2025-07-15	English
SUPPLEMENTARY ANNOUNCEMENT ANNUAL REPORT 2024 CONTINUING CONNECTED TRANSACTIONS Regulatory Filings	2025-07-07	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2025-07-02	English
PASSING AWAY OF CO-CHAIRMAN Board/Management Information	2025-07-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Regulatory Filings	2025-07-02	English
Change of Share Registrar and Transfer Office Regulatory Filings	2025-07-02	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2025 Regulatory Filings	2025-07-02	English
Discloseable Transaction - Subscription of Wealth Management Product with Industrial Bank Regulatory Filings	2025-06-19	English
Poll Results of the Annual General Meeting held on 19 June 2025 Declaration of Voting Results & Voting Rights Announcements	2025-06-19	English
Discloseable Transaction - Subscription of Wealth Management Products with Industrial Bank Regulatory Filings	2025-06-11	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2025 Regulatory Filings	2025-06-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Regulatory Filings	2025-06-02	English
Announcement Pursuant to Rule 13.18 of the Listing Rules Capital/Financing Update	2025-05-30	English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 28 MAY 2025 Declaration of Voting Results & Voting Rights Announcements	2025-05-28	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2025 Regulatory Filings	2025-05-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Regulatory Filings	2025-05-02	English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (or at any adjournment thereof) Proxy Solicitation & Information Statement	2025-04-29	English
NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-04-29	English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF THE RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-04-29	English
Annual Report 2024 Regulatory Filings	2025-04-29	English
Notification Letter to Non-registered Shareholders and Request Form Report Publication Announcement	2025-04-28	English
Notification Letter to Existing Shareholders and Request Form Report Publication Announcement	2025-04-28	English
Notice of Annual General Meeting Proxy Solicitation & Information Statement	2025-04-28	English
Form of Proxy for Annual General Meeting to be held on 19 June 2025 Proxy Solicitation & Information Statement	2025-04-28	English
General Mandates to Issue Shares and to Buy Back Shares, Declaration of Final Dividend, Re-election of Directors and Notice of Annual General Meeting Proxy Solicitation & Information Statement	2025-04-28	English
Annual Report 2024 Annual Report FY 2024	2025-04-28	English
Unaudited Financial Results for the three months ended 31 March 2025 of Tianjin Lisheng Pharmaceutical Co., Ltd. Interim / Quarterly Report Q1 2025	2025-04-25	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-08	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2025 Regulatory Filings	2025-04-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Regulatory Filings	2025-04-01	English
Final Dividend for the year ended 31 December 2024 Notice of Dividend Amount	2025-03-28	English
Announcement of Final Results for the year ended 31 December 2024 Annual Report FY 2024	2025-03-28	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024 Interim / Quarterly Report FY 2024	2025-03-26	English
Audited Financial Results for the year ended 31 December 2024 of Tianjin Lisheng Pharmaceutical Co., Ltd. Audit Report / Information FY 2024	2025-03-20	English
Date of Board Meeting Regulatory Filings	2025-03-17	English
POSITIVE PROFIT ALERT Earnings Release FY 2024	2025-03-10	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-03-10	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2025 Regulatory Filings	2025-03-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Regulatory Filings	2025-03-03	English
Completion of Share Repurchases and Adoption of Share Award Scheme by a Listed Subsidiary Transaction in Own Shares	2025-02-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-04	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2025 Regulatory Filings	2025-02-04	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2024 Regulatory Filings	2025-01-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Regulatory Filings	2025-01-06	English

Filings by year

2026 21 filings
2025 83 filings
2024 93 filings
2023 85 filings
2022 95 filings
2021 88 filings
2020 78 filings
2019 68 filings
2018 75 filings
2017 117 filings
2016 74 filings
2015 49 filings
2014 34 filings
2013 31 filings
2012 34 filings
2011 32 filings
2010 36 filings
2009 43 filings
2008 25 filings
2007 40 filings
2006 31 filings
2005 23 filings
2004 32 filings
2003 27 filings
2002 11 filings
2001 16 filings
2000 12 filings
1999 5 filings